Trials / Unknown
UnknownNCT03456570
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to determine whether the use of progesterone only pills has a beneficial effect over the expectant management of functional ovarian cyst or not , through a sample of female patients within the reproductive years
Detailed description
An ovarian cyst is a common gynecological problem and is divided into 2 main categories; physiological and pathological In relative frequency, functional cysts account for about 24% of all ovarian cysts, benign cysts 70% and malignant 6% Functional cysts are the most common masses seen in the premenopausal ovary and are estimated to affect 8%-20% of reproductive-aged women Pain or discomfort in the lower abdomen Severe pain from torsion (twisting) or rupture - Cyst rupture is characterized by sudden, sharp, unilateral pelvic pain; this can be associated with trauma, exercise, or coitus. Cyst rupture can lead to peritoneal signs, abdominal distention, and bleeding (which is usually self-limited) Discomfort with intercourse, particularly deep penetration Changes in bowel movements such as constipation Pelvic pressure causing tenesmus or urinary frequency Menstrual irregularities Precocious puberty and early menarche in young children Abdominal fullness and bloating Indigestion, heartburn, or early satiety Hyperpyrexia - This may result from some complications of ovarian cysts, such as ovarian torsion Adnexal or cervical motion tenderness In current clinical practice , gynecologists treat functional ovarian cysts with either oral Contraceptive pills or expectant management alone. we presume using progesterone only pills for treatment of functional ovarian cyst
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dydrogesterone 10 mg | Dydrogesterone 10 mg twice daily |
| DRUG | Placebo Oral Tablet | oral tablets twice daily |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2020-05-01
- Completion
- 2020-09-01
- First posted
- 2018-03-07
- Last updated
- 2018-03-07
Source: ClinicalTrials.gov record NCT03456570. Inclusion in this directory is not an endorsement.